Cargando…

Correction: CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

Detalles Bibliográficos
Autores principales:	Yang, Xiaojing, Karuturi, R. K. Murthy, Sun, Feng, Aau, Meiyee, Yu, Kun, Shao, Rongguang, Miller, Lance D., Tan, Patrick Boon Ooi, Yu, Qiang
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674778/ http://dx.doi.org/10.1371/annotation/e70583a2-3581-4848-b1e3-b518ac07d3a6

Ejemplares similares

CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
por: Yang, Xiaojing, et al.
Publicado: (2009)

CDKN1C/p57(kip2 )is a candidate tumor suppressor gene in human breast cancer
por: Larson, Pamela S, et al.
Publicado: (2008)

Knockdown of CDKN1C (p57(kip2)) and PHLDA2 Results in Developmental Changes in Bovine Pre-implantation Embryos
por: Driver, Ashley M., et al.
Publicado: (2013)

Regulation of p27(Kip1) and p57(Kip2) Functions by Natural Polyphenols
por: Russo, Gian Luigi, et al.
Publicado: (2020)

Cdkn1c (p57(Kip2)) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7
por: Andrews, Stuart C, et al.
Publicado: (2007)

Functional Versatility of the CDK Inhibitor p57(Kip2)
por: Creff, Justine, et al.
Publicado: (2020)

A Beckwith–Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57(Kip2)
por: Stampone, Emanuela, et al.
Publicado: (2021)

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
por: Pinton, Giulia, et al.
Publicado: (2021)

Akt destabilizes p57(Kip2): Akt at the converging crossroad?
por: Lo, Hui-Wen
Publicado: (2013)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
por: Pinton, Giulia, et al.
Publicado: (2022)

p57 kip2 immunohistochemistry: ancillary technique in hydatidiform moles diagnosis
por: Fernández, Jessica, et al.
Publicado: (2013)

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
por: Guo, Mengjun, et al.
Publicado: (2022)

Immunohistochemical Expression of p27(Kip1), p57(Kip2), Cyclin D1, Nestin, and Ki-67 in Ependymoma
por: Iqneibi, Shahad, et al.
Publicado: (2022)

EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation
por: Kuroki, Hideyuki, et al.
Publicado: (2014)

The CDK inhibitor p57(Kip2) enhances the activity of the transcriptional coactivator FHL2
por: Kullmann, Michael Keith, et al.
Publicado: (2020)

EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
por: Béguelin, Wendy, et al.
Publicado: (2017)

Decreased expression of p57(KIP2)mRNA in human bladder cancer
por: Oya, M, et al.
Publicado: (2000)

MicroRNA-21 inhibits p57(Kip2) expression in prostate cancer
por: Mishra, Sweta, et al.
Publicado: (2014)

p57(Kip2) is an essential regulator of vitamin D receptor-dependent mechanisms
por: Takahashi, Katsuhiko, et al.
Publicado: (2023)

ZAC, LIT1 (KCNQ1OT1) and p57(KIP2) (CDKN1C) are in an imprinted gene network that may play a role in Beckwith–Wiedemann syndrome
por: Arima, Takahiro, et al.
Publicado: (2005)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

Clinical Usefulness of Immunohistochemical Staining of p57(kip2) for the Differential Diagnosis of Complete Mole
por: Sasaki, Shigeru, et al.
Publicado: (2015)

High Dosage Lithium Treatment Induces DNA Damage and p57(Kip2) Decrease
por: Stampone, Emanuela, et al.
Publicado: (2020)

p57(Kip2) imposes the reserve stem cell state of gastric chief cells
por: Lee, Ji-Hyun, et al.
Publicado: (2022)

Dnmt3a Regulates Proliferation of Muscle Satellite Cells via p57Kip2
por: Naito, Masashi, et al.
Publicado: (2016)

Dorsal-Ventral Differences in Neural Stem Cell Quiescence Are Induced by p57(KIP2)/Dacapo
por: Otsuki, Leo, et al.
Publicado: (2019)

Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57(Kip2)
por: Kullmann, Michael Keith, et al.
Publicado: (2021)

p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion
por: Kapeni, Chrysa, et al.
Publicado: (2022)

The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer
por: Coley, H M, et al.
Publicado: (2012)

High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma
por: Yang, Chengcheng, et al.
Publicado: (2015)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect
por: Kavanagh, E, et al.
Publicado: (2012)

Relevance of immunohistochemical expression of p57(kip2) in epithelial ovarian carcinoma- A systematic literature review
por: Madhuri, Thumuluru Kavitha, et al.
Publicado: (2012)

CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma
por: Ru, Yi, et al.
Publicado: (2017)

Fbxo22 promotes cervical cancer progression via targeting p57(Kip2) for ubiquitination and degradation
por: Lin, Min, et al.
Publicado: (2022)

HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling
por: Hu, Jiao-Jiao, et al.
Publicado: (2016)

Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57(CDKN1C) and TP53INP1 in mantle cell lymphoma
por: Li, Wei, et al.
Publicado: (2019)

Cell cycle-related genes p57kip2, Cdk5 and Spin in the pathogenesis of neural tube defects
por: Li, Xinjun, et al.
Publicado: (2013)

Loss of p57(KIP2) expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells
por: Takahashi, Sota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_stackl2fla980oaojst8c7srh9